Alan R. Boobis
- Pharmacology top 0.01%
- Health, Toxicology and Mutagenesis top 0.05%
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Oncology top 0.5%
- Co-authors
- Donald S. DaviesD. S. DaviesNigel J. GooderhamSandra MurrayRobert J. EdwardsOlavi PelkonenDS DaviesAlan Ducatman
- Topics
- Pharmacogenetics and Drug Metabolism (129 papers)Carcinogens and Genotoxicity Assessment (84 papers)Effects and risks of endocrine disrupting chemicals (60 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Alan R. Boobis
357 papers receiving 17.7k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Pharmacology 5.8k
- Health, Toxicology and Mutagenesis 4.6k
- Molecular Biology 4.3k
- Cancer Research 3.5k
- Oncology 3.1k
Countries citing papers authored by Alan R. Boobis
This map shows the geographic impact of Alan R. Boobis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Boobis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Boobis more than expected).
Fields of papers citing papers by Alan R. Boobis
This network shows the impact of papers produced by Alan R. Boobis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Boobis. The network helps show where Alan R. Boobis may publish in the future.
Co-authorship network of co-authors of Alan R. Boobis
This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Boobis. A scholar is included among the top collaborators of Alan R. Boobis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Boobis. Alan R. Boobis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Researchbreakdown → | 1432 |
| 7 | 135 | |
| 8 | 71 | |
| 9 | 144 | |
| 10 | 89 | |
| 11 | 77 | |
| 12 | 51 | |
| 13 | 12 | |
| 14 | 92 | |
| 15 | Phenotype or genotype | 2 |
| 16 | Differences between hepatic and extrahepatic tissues in the activation of 3 8 dimethyl 3h imidazo 4 5 f quinoxalin 2 amine to a mutagen in the ames salmonella test | 1 |
| 17 | 23 | |
| 18 | Microsomes and drug oxidations : proceedings of the 6th International Symposium, Brighton, Sussex, United Kingdom, 5-10 August 1984 | 1 |
| 19 | 28 | |
| 20 | Studies on the metabolic fate of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in man [proceedings]. | 4 |
About Alan R. Boobis
Alan R. Boobis is a scholar working on Chemical Health and Safety, Pharmacology and Cancer Research, having authored 364 papers that have together received 18.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (129 papers), Carcinogens and Genotoxicity Assessment (84 papers) and Effects and risks of endocrine disrupting chemicals (60 papers). The work is most often cited by research in Pharmacology (5.8k citations), Chemical Health and Safety (225 citations) and Health, Toxicology and Mutagenesis (4.6k citations). Alan R. Boobis has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Donald S. Davies, D. S. Davies, Nigel J. Gooderham, Sandra Murray, Robert J. Edwards, Olavi Pelkonen, Robert J. Edwards, DS Davies, Alan Ducatman and Jamie C. DeWitt. Their work appears in journals such as Science, Journal of Biological Chemistry and Environmental Science & Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.